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Probing interactions between HIV-1 reverse transcriptase and its 
DNA substrate with backbone-modified nucleotides 
Andreas Marx’, Martin Spichtyl , Mario Amacker*, Urs Schwitterl, Ulrich 
HObscher*, Thomas A Bickle3, Giovanni Maga4 and Bernd Giesel 
Background: To gain a molecular understanding of a biochemical process, 
the crystal structure of enzymes that catalyze the reactions involved is 
extremely helpful. Often the question arises whether conformations obtained 
in this way appropriately reflect the reactivity of enzymes, however. Rates that 
characterize transitions are therefore compulsory experiments for the 
elucidation of the reaction mechanism. Such experiments have been 
performed for the reverse transcriptase of the type 1 human 
immunodeficiency virus (HIV-1 RT). 
Results: We have developed a methodology to monitor the interplay between 
HIV-1 RT and its DNA substrate. To probe the protein-DNA interactions, the 
sugar backbone of one nucleotide was modified by a substituent that 
influenced the efficiency of the chain elongation in a characteristic way. We 
found that strand elongation after incorporation of the modified nucleotide 
follows a discontinuous efficiency for the first four nucleotides. The reaction 
efficiencies could be correlated with the distance between the sugar 
substituent and the enzyme. The model was confirmed by kinetic experiments 
with HIV-1 RT mutants. 
Conclusions: Experiments with HIV-1 RT demonstrate that strand-elongation 
efficiency using a modified nucleotide correlates well with distances between 
the DNA substrate and the enzyme. The functional group at the modified 
nucleotides acts as an ‘antenna’ for steric interactions that changes the optimal 
transition state. Kinetic experiments in combination with backbone-modified 
nucleotides can therefore be used to gain structural information about reverse 
transcriptases and DNA polymerases, 
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Introduction 
The reverse transcriptase (RT) of the human immunodefi- 
ciency virus type 1 (HIV-l) copies the single-stranded RNA 
genome of the retrovirus into double-stranded Dr\;A [l]. 
This is an essential step in the retroviral life cycle. HIV-1 
RT is widely targeted by many clinically approved drugs 
to combat AIDS [Z] and much knowledge of its structure 
and function has been gained recently. ,4 crystal structure 
of HIV-1 RT complexed with the inhibitor nevirapine 
suggests that the RT is an asymmetric dimer (p66/pSl) 
in which the polymerase domain of the 66 kDa subunit 
has a large cleft analogous to that of the Klenow fragment 
of Eschrichia coli DNA polymerase I [3]. More insights 
into the interactions of the protein with the primer-tem- 
plate complex were gained through the determination of 
crystal structures of a ternary complex between HIV-1 RT, 
double-stranded DN4 template-primer and a monoclonal 
antibody Fab fragment [4], and, more recently, from a 
complex of HIV-1 RT covalently linked to double-stranded 
DiYA template-primer and a 2’-deoxynucleotide triphos- 
phate [S]. These structures suggest that the most numerous 
nucleic-acid interactions with the protein occur primarily 
along the sugar-phosphate backbone of the DNA. We 
developed a method in which these interactions can be 
probed by the use of nucleotides that are modified at the 
sugar-phosphate backbone. 
According to the crystal structures of HIV-1 RT com- 
plexed with double-stranded DNA, the BY-PlO motif is 
involved in the correct alignment of the 3’ end of the 
primer terminus, as well as in the binding of the nucleo- 
tide triphosphate [6] (Figure 1). The @l&p13 motif was 
designated the primer grip, proposing that it maintains the 
primer terminus in the appropriate orientation. Further- 
more, the aH helix of the p66 thumb makes contacts with 
the sugar-phosphate backbone of the primer strand and 
might function as a track over which the primer-template 
complex moves during translocation. 
The assumption that these protein-DNA interactions are 
crucial for DNA polymerization catalyzed by HIV-1 RT 
was further supported by studies using mutants of HIV-1 
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Figure 1 
Polymerase active site of HIV-1 RT complexed with a DNA template- 
primer duplex. The enzyme backbone was built using the Ca coordinates 
[4] (PDB entry 1 HMI) and the program MOLOC 2.0 [21]. A ten-base 
DNA duplex with an overhanging nucleotide at the 5’ terminus was 
modeled with MACROMODEL V4.5 (Department of Chemistry, 
Columbia University, New York, NY 10027 [22]) from the P-atom 
positions (given in [4]). The first six base pairs including the overhanging 
nucleotide were constructed in A form and the rest of the duplex in 
B form. The double-stranded DNA was optimized with AMBER force 
field [23] implemented in MACROMODEL V4.5. The enzyme backbone 
is shown in green ribbon model and the DNA duplex as bicoloured 
ladder. The red part represents the primer strand, whereas the purple 
part represents the template strand. The amino acids that are closest to 
the primer strand are shown. Structural elements near the primer strand 
are dark blue. Graphical layout was produced with PREPI Vl .O (Imperial 
Cancer Research Technology; http://bonsai.lif.icnet.uk/peoplel 
suhail/prepi.html. 
RT [7-lo]. It remains uncertain, however, whether the 
crystal structures, which were obtained from crystals under 
nonoptimal conditions for the enzyme, appropriately reflect 
the action of the RT under conditions where the enzyme is 
in its active form. Our methodology provides a new insight 
into the function of HIV-1 RT in its active form and its 
resistance against nucleoside and non-nucleoside anti-HIV 
drugs caused by mutations of the enzyme. 
Results and discussion 
Chain elongation with wild-type HIV-1 RT 
To probe the protein interactions with the sugar-phos- 
phate backbone of a primer-template DNA complex we 
modified the sugar residue of a thymidine triphosphate at 
the 4’ position by substituting the 4’ hydrogen with an 
acetyl functionality (Figure 2) [11,12]. We expected an 
influence on the efficiency of phosphodiester-bond forma- 
tion at any position along the DNA polymerization pathway 
where the 4’ modification makes contact with any residue 
of the protein that is crucial for catalysis. 
Figure 2 
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Structure of the backbone-modified thymidine triphosphate. 
We have shown that HIV-I RT is able to incorporate 
the backbone-modified thymidine triphosphate into the 
growing DNA strand [ 121. In these experiments, we found 
that only 4’-acetyl thymidine has the right shape for incor- 
poration and post-incorporation chain elongation in Dh’A- 
strand synthesis catalyzed by HIV-l RT [12]. To probe 
the interactions of the 4’ modification with the enzyme 
surface, we incubated HIV-l RT with a DNA S’-32P-labelled 
ZO-base primer/40-base template complex in which a 
single adenosine moiety in the template strand demands 
the incorporation of a thymidine analogue at position 30 in 
the presence of dATP, dCTP, dGTP and the 4’-acety- 
lated thymidine triphosphate for various times, and ana- 
lyzed the reaction products using polyacrylamide gel 
electrophoresis (PAGE; Figure 3a). 
After incubation for 15 min, the formation of a 30-base reac- 
tion product indicated the complete incorporation of the 
4’-acetyl thymidine analogue. With increasing time, the 
additional formation of 31- and 33-base products were 
observed prior to the formation of the full-length 40-base 
product. The formation of a X-base reaction product was 
not detected in substantial amounts, indicating that elonga- 
tion to the 33mer was rapid. The DNA products in the 
range of 30-40 bases obtained in these experiments were 
quantified using phosphorimaging techniques (Figure 4). 
The data in Figure 4a indicate that the DNA strand is elon- 
gated by HIV-l RT after incorporation of the 4’-modified 
thymidine with a discontinuous efficiency of phosphodi- 
ester-bond formation for the first four nucleotides. 
In order to verify that the band pattern obtained reflects 
the interaction of the backbone modification with the 
protein and does not result from a natural pausing site, the 
reaction was performed in the presence of thymidine 
triphosphate (TTP) instead of the modified analogue 
(Figure 3, lane 9). This does not lead to the formation of 
substantial amounts of reaction products shorter than the 
40-base full-length product. Furthermore, to exclude the 
possibility that the base composition of the template is 
responsible for the discontinuous formation of reaction 
products, the base composition of the template, as well as 
the length of the primer-template complex was varied. 
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Figure 3 
Effect of 4’.modified thymidine triphosphate on 
DNA strand synthesis catalyzed with HIV-1 RT. (’ 
Shown is an autoradiogram of an 11% 
denaturing PAGE. The numbers on the left side ’ 
indicate the length of oligonucleotide 
synthesized in primer extension. (a) LM, line 
marker; lanes l-8, a 20-base DNA 32P-5’-end 
labelled primer (15 nM, 5’.d(GTGGTGCGAAT- 
TCTGTGGAT)) and 40-base DNA template 
(45 nM, 5’-d(TCGGTCGllCATCCTTGCTGA- 
TCCACAGAATTCGCACCAC)), dATP. dGTP, 
1 
dCTP (2 pM each), and the modified thymidine 
triphosphate (100 PM) incubated at 37°C for 
, 
’ 
several times with HIV-1 RT (0.2 U/g)) as 
indicated in the figure; lane 9, control reaction, 
as in lanes l-8 but with TTP (100 PM) instead 
of the modified thymidine triphosphate and 
incubation for 15 min. (b) Lanes l-7, same as 
in (a), but with HIV-1 RT Met1 84-+Val mutant; 
lane 8, control reaction. 
a) (W 
0 15 30 60 90120150180 15min 0 15 30 45 60 75 90 15 min 
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This did not effect any significant change in the elonga- 
tion pattern (data not shown). Recently published experi- 
ments, in which the same assay was employed and primer 
extension reactions were performed either in the absence 
of any TTP analog or in the presence of the 4’-acylated 
TTP analogue clearly showed that under the employed 
conditions HIV-1 RT is able to incorporate the 4’-acylated 
TTP analog opposite to an adenosine moiety in favour of 
the misincorporation of another dNTP [12]. This indicates 
that the band pattern observed is due to the incorporation 
of the modified nucleotide. 
Efficiency of chain elongations 
In order to quantify the nucleotide-incorporation efficiency 
at various points of the DNA polymerization pathway we 
used a gel-based? steady-state kinetic assay [13,1-F] and 
Figure 4 
employed unmodified as well as 4’-acylated D&A primers 
(see the Materials and methods section). The kinetic 
data obtained for both sets of reactions are quite striking 
(Table 1). When unmodified primers were used in the 
HIV-1 RT catalyzed primer extension no significant vari- 
ation in catalytic efficiency was observed in the region of 
investigation, whereas in primer extension of 4’-acylated 
primers discontinuous catalytic efficiency was observed. 
This demonstrates that the discontinuous efficiency of 
DNA synthesis observed when modified primers were 
employed is due to interactions of the modification with 
the enzyme surface and not to any natural variation in 
efficiency. Furthermore, it turned out that addition of 
the next nucleotide after incorporation of the I’-modi- 
fied thymidine is the least efficient step in the primer- 
extension pathway. 
Comparison of the effect of 4’-acylated 
thymidines on DNA synthesis catalyzed by 
HIV-1 RT (wt, wild type) and HIV-l RT 
(Met1 84+Val) mutant. Shown is the 
distribution of 30-40 base reaction products 
of the reactions presented in Figure 3 after 
several incubation times. The bars represent 
the proportion of radioactivity for a DNA 
reaction product to the entire radioactivity in 
the lane. The radioactivity was quantified 
using Phosphorlmaging techniques. 
(a) 
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Table 1 
DNA elongation efficiency of unmodified and 4’.modified 
primers catalyzed by HIV-1 RT (wt). 
Modified primer Unmodified orimer 
Entry Elongation event KdiA ‘Lax/K, 
1 30+31 3.8 x 1 O-3 4.0 x 1 o-2 
2 31-+32 1.6x 1O-2 4.6 x 1 O-2 
3 32-33 1.0x 10-I 5.0 x 1 O-2 
4 33+34 2.4 x 1 O-2 3.8 x 1 O-2 
We explain this band pattern as different interactions of 
the 4’ substituent at the nucleotide with different residues 
of the enzyme. The crystal structures of HIV-1 RT com- 
plexed with a double-stranded DNA substrate [4,5] suggest 
that the protein has very extensive contacts between the 
tip of the p9-plO hairpin (Met184) and the first nucleotide 
at the 3’ end of the primer strand (Figure 1). The second 
nucleotide from the 3’-primer end contacts the primer grip 
~12-pl3 at Met230 (Figure 1). In both cases backbone 
modifications in the primer strand should have major inter- 
actions with these enzyme motifs because the rigid peptide 
backbone is in close vicinity to the primer (Figure 5a,b). 
These interactions might result in a misalignment of the 
modified DNA substrate in the enzyme cleft. This mis- 
alignment or a perturbed binding of the enzyme with the 
modified DNA substrate could lead to a less efficient phos- 
phodiester-bond formation (Table 1, entries 1 and 2. modi- 
fied primer). The third nucleotide downstream from the 
3’-primer end is located farther away from the peptide 
backbone. The indole sidechain (Trp’266, Figure 1) of the 
aH helix is in close contact to this nucleotide, however [S]. 
Nevertheless, a more efficient elongation of the modified 
primer occurs and only small amounts of a 32-base reaction 
product are observed (Figures 3a and 4a; Table 1, entry 3, 
modified primer). We assume that at this position the 
repulsive interactions between the modified nucleotide 
and the enzyme can be avoided through rotation of the 
planar indole sidechain into the gap between the PlZ-(313 
and the aH motifs (Figure 5~). During further movement 
of the backbone modification through the polymerase cleft, 
interactions between the enzyme and the DNA primer- 
template sugar-phosphate backbone occur with the aH 
helix (and the fourth nucleotide from the 3’-primer end 
(Figure 5d). The efficiency is therefore reduced again 
(Table 1, entry 4? modified primer) and a 33-base reaction 
product accumulates. 
Reactions with mutants of HIV-1 RT 
These results demonstrate clearly that a 4’ substituent is 
able to edit the interactions of the protein with the sugar- 
phosphate backbone. Mutations of the protein at these 
crucial sites should therefore have a significant effect on 
the ability of the HIV-1 RT to elongate the 4’-acetylated 
primer. Met184 is located at the tip of the p sheets p9-plO 
of HIV-1 RT and is in close vicinity to the deoxyribose 
moiety of the terminal nucleotide of the primer strand 
(Figure 1) [4,5,7]. It is known that a variation at codon 184 
has a significant effect on the efficiency of the DNA syn- 
thesis [7]. A suitable mutant is the Metl84+Val mutant 
that has been studied extensively and confers resistance 
to the nucleoside analogue 3’-thiacytidine (3TC) [lS]. 
The substitution of methionine to the less bulkier valine 
[7] places the sidechain of the amino acid 184 at a more 
favorable distance to the deoxyribose moiety of the primer 
terminus. Indeed, the hletl84-+\‘al mutant [16] elongated 
the 4’-modified primer end with higher efficiency than 
the wild-type RT (Figures 3b and 4b). Quantification of 
every single elongation step was investigated as described 
above and revealed that the’addition of the first nucleo- 
tide to the modified primer terminus is no longer the 
rate-limiting step (Table 2). 
In comparison with the wild-type HIV-1 RT (Table l), 
the hletlX4-+Val mutant elongates the modified primer 
Figure 5 
30 + 31 
Interactions of the backbone modification with HIV-1 RT. The primer 
strand is red, the 4’-backbone modified thymidine is gold (the 
4’wsubstituent is illustrated as a ball), and the nearest structural 
elements of the enzyme are shown as a blue Ccc trace. The figure 
illustrates the translocation of the primer strand and the different 
protein interactions with the 4’ substituent at the 3’-primer end, and at 
positions 2, 3 and 4, respectively, from the 3’-end (a-d). 
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Table 2 
Efficiency of DNA elongation catalyzed by the HIV-l RT 
(Metl844fal) mutant. 
Entry Elongation event 
1 30+31 
2 31-z.32 
3 32433 
4 33434 
““dS.4 
7.9 x 1 o-1 
3.4 x 1 o-2 
6.5 x lo-’ 
1.1 x 10-2 
strand with a ZOO-fold higher efficiency (Vmax/Kh,), whereas 
the efficiency for natural substrates remains almost the 
same [15] or is only slightly enhanced [7]. These studies 
support the assumptions that Met184 makes extensive 
contacts with the sugar moiety of the nucleotide at the 
3’ end of the primer and plays a crucial role in the align- 
ment of the primer-template in the catalytic site of the 
DNA polymerase. 
Figure 6 
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Effect of 4’.modified thymidine triphosphate on DNA strand synthesis 
catalyzed with mutants of HIV-1 RT. Shown is an autoradiogram of an 
11% denaturing PAGE. The numbers on the left side indicate the 
length of oligonucleotide synthesized in primer extension. LM, line 
marker. Lane 1) 20-base DNA 32P-5’-end labelled primer (15 nM, 
5’-d(GTGGTGCGAATTCTGTGGAT)) and 40-base DNA template 
(45 nM, 5’-d(TCGGTCGTTCATCCllGCTGATCCACAGAAlTCGC- 
ACCAC)), dATP, dGTP, dCTP (2 PM each), and the modified 
thymidine triphosphate (100 PM) incubated at 37°C for 150 min with 
HIV-1 RT (0.2 U/pi); lane 2, same as in lane 1, but with HIV-1 RT 
(“all 79+Asp); lane 3, same as in lane 1, but with HIV-1 RT 
(LyslOS+Asn); lane 4, same as in lane 1, but with HIV-1 RT 
(Leul OO+lle); lane 5, same as in lane 1, but with HIV-l RT 
(“all 06+Ala). 
Resistance of HIV to inhibition by non-nucleoside inhib- 
itors of HIV-l RT arises within a few viral replication 
cycles upon treatment with a single inhibitor [17,18]. The 
non-nucleoside-resistance mutations are located around 
the inhibitor-binding pocket [19]. Two major regions where 
these mutations occur are the fi sheets containing p9, pl0 
and p6, and the loop between BSb and p6. These regions 
include mutations LeulOO+Ile, Lysl03+Asn, Val106-+Ala 
and Vall79-+Asp. The structural basis of the resistance to 
non-nucleoside inhibitors remains unclear as no structures 
of mutant HIV-1 RT bound with an inhibitor and DNA are 
known [19,20]. To monitor conformational changes of the 
mutated HIV-l RT we evaluated their action on the back- 
bone-modified thymidine analog. Incubation of HIV-l RT 
with the DNA 5’-“?P-labelled ZO-base primer/40-base tem- 
plate complex was performed as described above. The reac- 
tions with mutation in the crucial positions of HIV-1 RT 
[ 161 resulted in different band patterns to those of the wild- 
type enzyme (Figure 6). This indicates that the 4’-modi- 
fied nucleotide recognizes conformational differences within 
the DNA polymerase cleft and demonstrates that these 
mutations influence the conformation and orientation of the 
motifs of the HIV-l RT that are crucial for alignment of the 
DNA substrate in the enzyme cleft. These changes might 
influence the ability of the inhibitor to bind in the binding 
pocket and confer the apparent resistance. 
Significance 
Recently, the reverse transcriptase (RT) of the human 
immunodeficiency virus type 1 (HIV-l) has been studied 
extensively and crystal structure analyses and studies of 
mutants have increased our understanding about its 
structure and function. We have developed a new method- 
ology to monitor the interplay of HIV-1 RT with its 
DNA substrate. In order to probe the protein interac- 
tions with its DNA substrate the sugar backbone of a 
nucleotide was modified and the efficiency of chain elon- 
gation was measured. The backbone substituent acts as 
an ‘antenna’ and gives information on the distances 
between the nucleotides and the amino acids at different 
positions. This method offers a new and useful tool to 
derive structural information from kinetic experiments. 
By applying the technique to other reverse transcriptases 
or DNA polymerases, structural information about these 
enzymes in their active form might be deduced. The 
method is very flexible and the polarity, as well as the 
position, of the substituent at the sugar can be varied. 
Materials and methods 
Primer-extension reactions 
The 5’.end-labelled 20.base oligonucleotide primer was annealed to its 
complementary site on a 40-base oligonucleotide by heating the DNA 
primer to 60°C for 5 min and subsequent cooling to 25% within 1 h in 
the reaction buffer (20 mM Tris-HCI (pH 7.51, 6 mM MgCI,, 40 mM KCl, 
0.5 mM DlT). The reactions were performed as described previously 
(121. DNA sequences, nucleotide concentrations and enzyme amounts 
are given in Figures 3 and 6. The reactions were stopped by addition of 
formamide and subsequent heating to 90% and analyzed with an 11 O/o 
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polyacrylamide denaturating sequencing gel (National DiagnostiCs). After 
electrophoresis the gel was transferred to filter paper (Whatmann 3MM) 
and dried at 80°C. The radioactivity in the DNA bands was quantified 
using a Phosphorlmager (Molecular Dynamics). 
Steady-state kinetic assay 
The incorporation of the first nucleotide after the incorporated 4’-acety- 
lated nucleotide was measured through incubation of a 5’-32P-end- 
labelled 29-base primer (73 fmol, 5’-d(GTGGTGCGAATTCTGTGGA- 
TCAGCAAGGA)I40-base DNA template (230 fmol) template complex 
with HIV-1 RT (0.05 U) under saturating concentrations of 4’.acetyl 
thymidine triphosphate (200 PM) and various concentrations of dGTP 
in a final volume of 10 ~1. In a typical experiment only up to 20% of the 
primer was consumed during the reaction (data not shown). The kinetic 
constants K, and V,, and the substrate efficiency (V,~K,,,,) were 
determined for each reaction from quantification of the radioactivity in 
the bands at the desired nucleotide incorporation sites and the bands 
one position prior as described previously [13,14]. The kinetic parame- 
ters derived from the translocation of the 4’-modification through the 
enzyme cleft during the DNA polymerization pathway were obtained by 
standing-start polymerization reactions. The DNA substrates containing 
the 4’-backbone modifications (T*) at positions 2, 3, and 4, respec- 
tively, from the 3’-end of the primer strand were synthesized chemically 
via the phosphoamidite approach as described recently [ll]. DNA 
sequences of the 5’-32P-end labelled primers are: 31mer: 5’-d(GTG- 
GTGCGAATfCTGTGGATCAGCAAGGAT*G), 32mer: 5’-d(GTGGT- 
GCGAATTCTGTGGATCAGCAAGGAT’GA), 33mer: 5’-d(GTGGTG- 
CGAATlCTGTGGATCAGCAAGGAf*GAA). The primers were annealed 
to the appropriate 40.base DNA template and the reactions were per- 
formed in the presence of a single deoxynucleotide triphosphate (dNTP). 
The reactions resulted in the increased accumulation of extended 
primer as the dNTP concentration was increased. In a typical experi- 
ment only up to 20% of the primer was consumed during the reaction 
(data not shown). The kinetic constants K, and V,, and the substrate 
efficiency (V,dK<,) were determined as described above. 
Enzyme preparations 
The expression vectors for the HIV-l RT p66 mutants were kindly pro- 
vided by S.H. Hughes (NCI-Frederick Cancer Research and Develop- 
ment Center) and purified as described previously [161. Enzyme activities 
were determined as described previously [16]. 
Acknowledgements 
The authors gratefully acknowledge financial support from the Swiss 
National Science Foundation (NF AIDS program 3139-047297-96, NF 
20-9504-96 and NF 31-46768.96) and the Novartis AG. This work was 
supported by the TMR grant ERBMRXCT 970125 to U.H., by the CNR- 
target project on Biotechnology and by an ISS-AIDS fellowship to G.M. 
References 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
Luciw, P. (1996). Human immunodeficiency viruses and their 
replication. In Fundamental Virology (Fields, B.N., Knipe, D.M. & 
Howley, P.M., eds) pp. 845-916, Lippincott-Raven, New York. 
Hiibscher, U. & Spadari, S. (1994). DNA replication and 
chemotherapy. fhysiol. Rev. 74, 259-304. 
Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A. & Steitz, T.A. 
(1992). Crystal structure at 3.5 A resolution of HIV-l reverse 
transcriptase complexed with an inhibitor. Science 256, 1783-l 790. 
Jacobo-Molina, A., et al. & Arnold, E. (1993). Crystal structure of 
human immunodeficiency virus type 1 reverse transcriptase 
complexed with double-stranded DNA at 3.0 A resolution shows bent 
DNA. Proc. Nat/ Acad. Sci. USA 90, 6320-6324 
Huang, H., Chopra, R., Verdine, G.L. & Harrison, S.C. (1998). 
Structure of a covalently trapped catalytic complex of HIV-1 reverse 
transcriptase: implications for nucleoside analog drug resistance. 
Science 282, 1669-l 675. 
Patel, P.H., et al. & Arnold, E. (I 995). Insights into DNA polymerization 
mechanisms from structure and function analysis of HIV-1 reverse 
transcriptase. Biochemistry 34, 535 l-5363. 
Pandey, V.N., et al. & Modak, M.J. (1996). Role of methronine 184 of 
human immunodeficiency virus type-l reverse transcriptase in the 
polymerase function and fidelity of DNA synthesis. Biochemistry 35, 
2168-2179. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
- 
Wrlson, J.E., et al. & Furmann, P.A. (1996). Human cmmunodeficiency 
virus type-l reverse transcriptase. Contribution of Met-184 to binding 
of nucleoside 5’triphosphate. J. Biol. Chem. 271, 13656-l 3662. 
Wohrl, B.M., et al. & Goody, R.S. (1997). Kinetic analysrs of four HIV- 
1 reverse transcriptase enzymes mutated in the primer grip region of 
~66. Implications for DNA synthesis and dimerization. J. Biol. Chem. 
272,17581-l 7587. 
Ghosh, M., Williams, J., Powell, M.D., Levin, J.G. & Le Gnce, S.F.J. 
(1997). Mutating a conserved motif of the HIV-l reverse transcriptase 
palm subdomain alters primer utilization. Biochemistry 36, 5758-5768. 
Marx, A., et al. & Giese, B. (1996). Synthesis of 4’Cacylated 
thymidines. He/v. Chim. Acta 79, 1980-l 994. 
Marx, A., MacWilliams, M.P.. Bickle, T.A., Schwitter, U. & Giese, B. 
(1997). 4’.Acylated thymidines: a new class of DNA chain 
terminators and photocleavable building blocks. J. Am. Chem. Sot. 
119, 1131-1132. 
Randall, SK., Eritja, R., Kaplan, B.E., Petruska, J. 8 Goodman, M.F. 
(1987). Nucleotide insertion kinetics opposite abasic lesions in DNA, 
J. Biol. Chem. 282, 6864-6870. 
Boosalis, MS., Petruska, J. & Goodman, M.F. (1987). DNA 
polymerase insertion fidelity: gel assay for site-specific kinetics. /. Biol. 
Chem. 262, 14689-l 4686. 
Wainberg, M.A., et al. & Prasad, V.R. (1996). Enhanced fidelity of 
STC-selected mutant HIV-l reverse transcriptase. Science 271, 
1282-l 285. 
Maga, G., Amacker, M., Tuel, N., Hubscher, U. & Spadari, S. (1997). 
Resistance to nevirapine of HIV-l reverse transcriptase mutants: loss 
of stabilizing interactions and thermodynamic or steric barriers are 
induced by different single amino acid substitutions. J. Mol. Biol. 274, 
738-747. 
Nunberg, J.H., et al. &Goldman, M.E. (1991). Viral resistance to 
human immunodeficiency virus type 1 -specific pyridinone reverse 
transcriptase inhibitors. J. Viral. 65, 4887-4891. 
Mellors, J.W., et al. & Cheng, Y.C. (1992). In vitro selectron and 
molecular characterization of human immunodeficiency vrrus-1 
resistant to non-nucleoside inhibitors of reverse transcriptase. Mol. 
Pharmacol. 41,446-451, 
Tantillo, C., et al. & Arnold, E. (1994). Locations of anti-AIDS drug 
binding sites and resistance mutations in the three-dimensional 
structure of HIV-l reverse transcriptase. lmpkcations for mechanisms 
of drug inhibition and resistance. 1. Mol. Biol. 243, 369-387. 
Das, K., et al. & Arnold, E. (1996). Crystal structure of 8-Cl and 9-Cl 
TIBO complexed with wild-type HIV-l RT and 8-C TIBO complexed 
with the Tyrl 81Cyc HIV-l RT drug resistance mutant. J. Mol. Biol. 
264, 1085-l 100. 
Gerber, P.R. & Muller, K. (1995). MAB, a generally applicable 
molecular force field for structure modeling in medicinal chemistry. 
J. Comput. A/ded Mol. Design 9, 251-268. 
Mohamadi, F., et a/. & Still. W.C. (1990). MacroModel - an integrated 
software system for modeling organic and bioorganic molecules using 
molecular mechanics. J. Compuf. Chem. 41, 440-467. 
Weiner, S.J., et al. & Weiner, P.A. (I 984). A new force field for 
molecular mechanical simulations of nuclerc acids and proteins. 
J. Am. Chem. Sot. 106. 765-784. 
Because Chemistry & Biology operates a ‘Continuous 
Publication System’ for Research Papers, this paper has been 
published via the internet before being printed. The paper can 
be accessed from http://biomednet.com/cbiology/cmb - for 
further information, see the explanation on the contents pages. 
